⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMRN News
BioMarin Pharmaceuticals Inc
Form 8-K
sec.gov
BMRN
Global TDP-43 Antibody Market Outlook and Forecast, 2026-2032 - Market to Reach USD 508.93 Million at 12.03% CAGR as Validated Antibodies, AI-Powered Imaging, and Neurodegenerative Research Create New Growth Opportunities
globenewswire.com
ABBV
ABT
ABM
BIO
BIIB
BMRN
CRSP
DHR
EXAS
GILD
ILMN
INCY
ISRG
JNJ
LULU
MDLZ
MRK
NVS
PFE
REGN
ROST
SNPS
SRPT
STX
TMO
TSLA
VRTX
WDC
PEGylated Proteins Market - Global Forecast 2026-2032
globenewswire.com
TMO
NVO
MRK
PFE
TAK
BIIB
BMRN
VTRS
Form 8-K
sec.gov
TVTX
AMTX
BMRN
LNT
Form 8-K
sec.gov
BMRN
Red Biotechnology Market Set for Robust Growth Through 2035, Fueled by Precision Medicine, Gene Therapies and Biopharmaceutical Innovation
globenewswire.com
PFE
BIIB
AMGN
AZN
GILD
MRK
BMY
REGN
LLY
NVS
BMRN
AMTX
Form 8-K
sec.gov
BMRN
BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors
prnewswire.com
BMRN
Mucopolysaccharidosis I - Market Insights, Epidemiology, and Market Forecast to 2036. MPS I Market Set for 8.6% Growth Through 2036
globenewswire.com
BMRN
BioMarin Announces Positive Results of Phase 3 VOXZOGO® (vosoritide) Study in Hypochondroplasia Published in NEJM Evidence
prnewswire.com
BMRN